Answer
KIMMTRAK (tebentafusp) is contraindicated in patients with hypersensitivity to tebentafusp or any excipient listed in section 6.1 of its product information.
Sources for this answer
- KIMMTRAK (tebentafusp) 200 micrograms/ mL concentrate for solution for infusionImmunocore Limited · emc · SmPC §4.3 Contraindications · Version 2Document updated
Sources checked